Semaglutide, known as Ozempic, may reduce alcohol cravings and consumption, offering new addiction treatment possibilities.

Rybelsus (semaglutide) is a brand-name oral tablet prescribed for type 2 diabetes. As with other drugs, Rybelsus can cause side effects, such as nausea, vomiting, and constipation. Read on to ...

Semaglutide's role extends beyond diabetes, aiding weight loss and offering cardiovascular protection, with ongoing research ...

If it reaches the market, the oral formulation could have a ... "Delivering protein-based medicine like semaglutide in the form of a tablet and producing it on a large scale is a major challenge ...

This article was reviewed by Craig Primack, MD, FACP, FAAP, FOMA. Semaglutide — the active ingredient in the brand-name meds Ozempic, Wegovy, and Rybelsus — treats type 2 diabetes and obesity ...

Semaglutide is a GLP-1 agonist that works by reducing appetite, delaying gastric emptying, increasing insulin release, and lowering the amount of glucagon released. Semaglutide is a glucagon-like ...

A small study confirms observations what users have observed: the medications reduce their cravings for alcohol.

Rybelsus is an oral tablet best taken on an empty stomach ... your body may absorb less of the active ingredient (semaglutide). Having a lower amount of the drug can make Rybelsus less effective.

Semaglutide could help people drink less alcohol. Semaglutide, a medication widely used for diabetes and weight loss, may offer another unexpected benefit -- it could help people drink less ...

A new study showed that semaglutide may help with alcohol use disorder Cara Lynn Shultz is a writer-reporter at PEOPLE. Her work has previously appeared in Billboard and Reader's Digest.

Pursuing the world's first-ever orally-dosed liraglutide KELOWNA, BC / ACCESS Newswire / February 20, 2025 / Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW) (the "Company" or "Lexaria"), a global ...